Global Cord Blood (NYSE:CO) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO) in a research report sent to investors on Saturday morning. The brokerage issued a strong-buy rating on the medical research company’s stock.

Global Cord Blood Price Performance

Global Cord Blood stock opened at $1.75 on Friday. Global Cord Blood has a twelve month low of $2.03 and a twelve month high of $5.50. The company has a market capitalization of $212.71 million, a P/E ratio of 2.73 and a beta of 0.16. The stock’s 50 day moving average is $1.27 and its 200 day moving average is $1.36.

About Global Cord Blood

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.